新药品价值评估研究

发布时间：2018-03-10 07:11

本文选题：新药品　切入点：价值评估　出处：《云南财经大学》2014年硕士论文　论文类型：学位论文

【摘要】：改革开放以来，我国医药产业得到了快速发展，，支撑医药产业发展的是新药品的研发，新药品研发成为了医药企业在市场上获取竞争地位的主要途径之一。我国新药技术转让每年的交易金额近百亿，新药品价值评估研究具有重大的理论及现实意义。由于新药品的研发具有高投入、高技术、高风险、周期长和过程复杂等特点，使形成的新药品价值具有高成本和高附加值，二者对新药品价值起着决定性作用。本文将新药品研发周期划分为三个阶段，运用马克思主义经济学、资产评估学、等多种理论和方法，对每个阶段新药品价值的形成、影响因素和评估方法进行了深入系统的分析和研究。指出新药品价值包含基本价值、技术价值、使用价值和经济价值；指出影响新药品价值的因素主要包括新药品的研发成本、功能、技术有效期、技术水平、医药政策法规和市场因素，介绍了它们如何对新药品价值产生影响；比较各评估方法后，指出了处于不同阶段的新药品价值的评估应采用不同的评估方法；针对新药品价值评估，对广泛使用的收益法模型进行调整，对模型中各参数的确定进行详细了分析。另外，本文还加入案例分析，对某新药品价值的评估进行了评估，旨在以实例说明新药品价值评估的过程、计算的关键因素、评估中应注意的事项。本文分为七个部分，系统的梳理了新药品价值评估过程中影响因素，调整了传统的收益法模型，通过参数量化影响因素的作用，使估值模型更适应新药品价值的评估。文中案例分析体现了理论分析对实际运用的指引，使调整后的模型更具有实践意义。总的来说，本文系统地论述了新药品价值评估研究的主要理论和观点，为新药品价值评估问题研究做出有益的探索。
[Abstract]:Since the reform and opening up, the pharmaceutical industry in China has developed rapidly. The development of new drugs is supported by the development of the pharmaceutical industry. New drug research and development has become one of the main ways for pharmaceutical enterprises to gain competitive position in the market. The annual transaction amount of new drug technology transfer in China is nearly 10 billion, so the research of new drug value evaluation has great theoretical and practical significance. Because of the characteristics of high investment, high technology, high risk, long period and complicated process, the new drugs have high cost and high added value. This paper divides the research and development cycle of new drugs into three stages, and applies various theories and methods, such as Marxist economics, asset appraisal, etc, to the formation of new drug value in each stage. The influence factors and evaluation methods are analyzed and studied deeply and systematically. It is pointed out that the value of new drugs includes basic value, technical value, use value and economic value, and that the factors influencing the value of new drugs mainly include the cost of research and development of new drugs. Function, technical validity period, technical level, medical policy, regulations and market factors, how they have an impact on the value of new drugs. This paper points out that different methods should be used to evaluate the value of new drugs at different stages, adjusts the widely used income method model, and analyzes in detail the determination of the parameters in the model. This paper also introduces a case study to evaluate the value of a new drug. The purpose of this paper is to illustrate the process of value evaluation of new drugs, the key factors of calculation, and the matters needing attention in the evaluation. This paper is divided into seven parts, systematically combing the influence factors in the process of new drug value evaluation, adjusting the traditional income model, and quantifying the effect of the factors through the parameters. The case analysis in this paper reflects the guidance of the theoretical analysis to the practical application and makes the adjusted model have more practical significance. In general, this paper systematically discusses the main theories and viewpoints of new drug value evaluation, and makes a useful exploration for the study of new drug value evaluation.
【学位授予单位】：云南财经大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：F426.72;F233

【参考文献】